|
|||||
|
|
Efficacy and safety of dronedarone in patients with a prior ablation for atrial fibrillation/flutter: Insights from the ATHENA study |
|
| Authors: | Mate Vamos Hugh Calkins Peter R. Kowey Christian T. Torp-Pedersen Valérie Corp dit Genti Mattias Wieloch Andrew Koren Stefan H. Hohnloser |
| Affiliation: | 1. J.W. Goethe University, Department of Cardiology, Division of Clinical Electrophysiology, Frankfurt, Germany University of Szeged, Second Department of Medicine and Cardiology Center, Szeged, Hungary;2. Johns Hopkins University, Department of Medicine, Cardiology, Baltimore, Maryland;3. Lankenau Heart Institute, Department of Cardiology, Wynnewood, Pennsylvania;4. Nordsjaellands Hospital, Department of Cardiology and Epidemiology, Hillerød, Denmark;5. Sanofi-Aventis, Paris, France;6. Sanofi-Aventis, Paris, France Lund University, Department of Clinical Sciences, Malmö, Sweden;7. Sanofi US Inc., Bridgewater, New Jersey;8. J.W. Goethe University, Department of Cardiology, Division of Clinical Electrophysiology, Frankfurt, Germany |
| Abstract: | |
| Keywords: | ablation antiarrhythmic drug atrial fibrillation atrial flutter dronedarone |